Google Deepmind shifts genomics AI from bulk tissue predictions to single cell type resolution with AlphaGenome 2
The Decoder ·
Summary
Google Deepmind has unveiled AlphaGenome 2, an AI model that analyzes genetic variants for individual cell types rather than across bulk tissue. Trained on more than 107 million cell profiles, it identifies nearly twice as many disease-relevant gene changes as its predecessor. Th
- Source
- The Decoder
- Published (IST)
Original reporting belongs to The Decoder. DEEKOYA links the headline and a short excerpt only; we do not republish the full article.
Explore more: Today in AI · Research papers · AI tools · Learn AI
Related stories
- iAfrica.com
Kenya’s Financial Centre Plans $500m Fund, With Half for Tech and AI Startups
iAfrica.comAI
- Cureus
When Forecasts May Amplify Drug Shortages: Artificial Intelligence and Medication Supply Governance
CureusAI
- 24/7 Wall St.
Taiwan Semiconductor Just Became Even More of an AI Anchor On Nvidia’s -25% Plummet
24/7 Wall St.Hardware
- PR Newswire
Hypotheses Scaled. Verification Didn't. SciGround Debuts as a Mathematical Verification Layer for LLM-Driven Research
PR NewswireResearch
- Mezha.net
UK has no intention of adapting to EU AI rules
Mezha.netPolicy
- Robotics Tomorrow
Manufacturing’s Next Phase: From AI Pilots to Autonomous Decisions on the Factory Floor
Robotics TomorrowAI
Who reported “Google Deepmind shifts genomics AI from bulk tissue predictions to single cell…”?
The Decoder, on 12 Nov 2026. The full article is at the source link on this page.
Comments
No comments yet. Share your own experience below.
Visitor posts are moderated before they appear and are the opinion of their authors, not DEEKOYA AI. Names are not verified. See our privacy policy.